Employer-Sponsored Fertility and Family-Building Benefits Among 928 U.S. Employers. [PDF]
CureusBaloch KF, Saghar V, Gulati R.
europepmc +1 more source
A framework to evaluate surrogate endpoints at the trial level: analysis in colorectal cancer. [PDF]
J Natl Cancer InstChia BJ +5 more
europepmc +1 more source
Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis. [PDF]
CancerLeong R +7 more
europepmc +1 more source
Independent surrogacy journeys without agency intervention: an ethnographic study of surrogates' experiences. [PDF]
Front Glob Womens HealthKonvalinka NA, Ayala A.
europepmc +1 more source
Surrogacy from a reproductive rights and justice perspective: a narrative review. [PDF]
Reprod FertilLherbet M, Hamamah S.
europepmc +1 more source
Shared struggles: Muslim, migrant, lesbian, gay, single and older experiences of accessing assisted reproductive technology. [PDF]
Int J Equity HealthDavies SG, Martin-Anatias N, Truyts C.
europepmc +1 more source
Motherhood, the "blank slate," and the language of surrogacy. [PDF]
Front Glob Womens HealthGribble KD.
europepmc +1 more source
Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies. [PDF]
LeukemiaSimon F, Al-Sawaf O.
europepmc +1 more source
Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis. [PDF]
CancerMartinez C +7 more
europepmc +1 more source
Towards a universal legal framework: The necessity of international legal regulation for surrogacy
Kabarak Law ReviewThe global rise of surrogacy, both as a medical practice and a commercial arrangement, has outpaced the development of international legal frameworks, leading to significant ethical, legal, and human rights concerns.
Rebecca Andeso
doaj